scholarly article | Q13442814 |
P2093 | author name string | A Greinacher | |
T Bakchoul | |||
H Zöllner | |||
P2860 | cites work | Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells | Q28378442 |
Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia | Q33338031 | ||
Platelet activation induced by human antibodies to interleukin-8. | Q33344855 | ||
Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy | Q33362744 | ||
Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. | Q33363743 | ||
Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? | Q33369345 | ||
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings | Q33370951 | ||
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia | Q33374563 | ||
Heparin-induced thrombocytopenia associated with interleukin-8-dependent platelet activation in a patient with antiphospholipid syndrome | Q33377151 | ||
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays | Q33379665 | ||
Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia | Q33384405 | ||
Thrombin generation and heparin-induced thrombocytopenia | Q33385116 | ||
Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia | Q33390069 | ||
Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests | Q33390721 | ||
The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion | Q33391945 | ||
Simple scoring system for early management of heparin-induced thrombocytopenia | Q33393295 | ||
Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT). | Q33393645 | ||
The diagnostic value of the anti-PF4/heparin immunoassay high-dose heparin confirmatory test in cardiac surgery patients | Q33394426 | ||
Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay | Q33395541 | ||
Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study | Q33399117 | ||
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis | Q33403395 | ||
Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia | Q33405500 | ||
Novel diagnostic assays for heparin-induced thrombocytopenia | Q33406133 | ||
FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Q33406804 | ||
Multicentric validation of a rapid assay for heparin-induced thrombocytopenia with different specimen types. | Q33412281 | ||
Heparin‐induced thrombocytopenia: an improved method of detection based on lumi‐aggregometry | Q33488521 | ||
Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia | Q33494985 | ||
Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia | Q33495595 | ||
A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry | Q33498117 | ||
Rapid detection of heparin-induced platelet antibodies with particle gel immunoassay (ID-HPF4) | Q55033407 | ||
P433 | issue | 3 | |
P304 | page(s) | 296-305 | |
P577 | publication date | 2014-06-01 | |
P1433 | published in | International Journal of Laboratory Hematology | Q15751320 |
P1476 | title | Current insights into the laboratory diagnosis of HIT. | |
P478 | volume | 36 |
Q33430644 | An update on heparin-induced thrombocytopenia: diagnosis and management |
Q50090659 | Clinical Significance of the Serotonin Release Assay and Platelet Count Monitoring After Cardiac Surgery. |
Q33425840 | Current management of heparin-induced thrombocytopenia |
Q90029506 | Drug-associated thrombocytopenia |
Q33429893 | Evaluation of flow cytometric HIT assays in relation to an IgG-specific immunoassay and clinical outcome |
Q33440890 | Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A Review |
Q49711717 | Heparin-Induced Thrombocytopenia and Thrombosis: Preventing your Thrombolysis Practice from Taking a HITT. |
Q54678301 | Laboratory Testing Protocols for Heparin-Induced Thrombocytopenia (HIT) Testing. |
Q48256739 | Laboratory tests for identification or exclusion of heparin induced thrombocytopenia: HIT or miss? |
Q33440090 | New platelet functional method for identification of pathogenic antibodies in HIT patients |
Q33416315 | Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study |
Q33420446 | Severe and persistent heparin-induced thrombocytopenia despite fondaparinux treatment |
Q42037184 | Use of the ID-PaGIA Heparin/PF4 Antibody Test as a screening test for heparin/platelet factor 4 antibodies |
Search more.